Virginia Ko, Financial Advisor at Morgan Stanley

With so many unknowns about reopening the economy, investors should probably remain cautious about buying the market. See three key outstanding questions:

Stocks fall modestly to start the week as oil records historic decline; Read more in the 1% Move report:

The steep decline in oil prices is a fascinating story of demand, supply and even game theory. But Chief Cross-Asset Strategist Andrew Sheets says that story could reverse next year.

Get online access to your account documents, use less paper and help preserve the environment by signing up for eDelivery.

Sign up for eDelivery to get access to your online account from any device and receive email notifications as soon as eligible account documents are available.

Stocks notch a second consecutive week of gains as optimism returns to Wall Street. Read more in the 1% Move report:

True financial literacy can be taught at home. This #FinancialLiteracyMonth, take the opportunity to have the conversation with your children about good money habits. We can help. #financialliteracy

Emerging markets recovered quickly from the 2008 financial crisis, but could a more challenging backdrop in 2020 mean a different outcome this time? Insights from Chief Economic Adviser Reza Moghadam.

Help protect access to your account with more than just a password. At Morgan Stanley, you can chose the authentication option that works best for you.

For investors in municipal bonds, the Fed’s recent creation of the Municipal Liquidity Facility and Mainstreet Lending Facility is a key positive. Head of Municipal Strategy Michael Zezas explains why.

To help you stay informed, we've established a new resource center to share our perspective on how COVID-19 is impacting the markets and the economy, remind you about ways to stay connected with us from your home, and answer your questions. Let me know if you want to connect anytime.

US stocks lower on Wednesday as economic and earnings data in focus. Read more in the 1% Move report:

When do we return to work? The market reaction? The drug pipeline? Chief Cross-Asset Strategist Andrew Sheets and Head Biotech Equity Analyst Matthew Harrison continue their discussion on the impact of the Covid-19 pandemic.